Delivery Order SPE2DB22D2206-SPE2DB25FEA13
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,636.56 firm fixed-price delivery order is for the medication TOVIAZ ER 4 MG TABLET 30S. The contract has a completion date of July 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,778.94 firm-fixed-price delivery order is for the supply of TOVIAZ ER 8 MG TABLET 30S, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.41, is for the delivery of TOVIAZ ER 8 MG TABLET 30S, a prescription pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 14, 2025. The award is not associated with a set-aside program and appears to be part of a larger...
- This federal contract award is a delivery order valued at $1,222.74 for the pharmaceutical product TOVIAZ ER 4 MG TABLET 30S. The award was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 22, 2025 and is a firm fixed price arrangement. The contract does not have a set-aside designation, indicating it was competitively...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,763.99 firm-fixed-price delivery order is for the pharmaceutical product TOVIAZ ER 8 MG TABLET 30S. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,242.42 fixed-price contract is for the delivery of Toviaz ER 8 mg tablets, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, valued at $1,461.42, is for the delivery of the pharmaceutical product TOVIAZ ER 8 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor for this delivery order contract. The contract is a firm fixed-price arrangement with a completion date of July 11, 2024....
- This federal contract award, with an ID of SPE2DB22D1106|SPE2DB24FEXD6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,706.11 firm-fixed-price delivery order is for the supply of 4564910533 TOVIAZ ER 4 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2024 and was awarded on June 14, 2024. AmerisourceBergen, a for-profit organization,...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D1004) under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,817.58. The contract is for the delivery of TOVIAZ ER 4 MG TABLET 30S, a pharmaceutical product, with a completion date of October 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award, with the identifier SPE2DB20D2104|SPE2DB25FMHRM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,553.81, is a Firm Fixed Price Delivery Order for the supply of TOVIAZ ER 4 MG TABLET 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FEA13Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,014.82, is for the supply of TOVIAZ ER 8 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price, delivery order contract. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 10/30/24 |